检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:耿嘉正[1] 周静[2] 张思仲[1] 贺勇[3] 马用信[1]
机构地区:[1]四川大学华西医院医学遗传室,四川成都610041 [2]四川大学华西医院临床检验科,四川成都610041 [3]四川大学华西医院心内科,四川成都610041
出 处:《华西医学》2006年第2期286-287,共2页West China Medical Journal
基 金:国家自然科学基金重大项目(39993420)~~
摘 要:目的探讨血小板膜P2Y_(12)受体介导的血小板活化及凝血激活与冠心病的关系及临床意义。方法采用病例对照研究,检测238例中国四川地区[冠心病(coronayatheroscleroticheartdisease,CHD)组177例,对照(control)组61例]血小板最大聚集度(Maximumplateletaggregationratio,MAR)、血浆P选择素(granulemembraneprotein,GMP140)及各项凝血指标。结果冠心病组与对照组比较,MAR、GMP140、纤维蛋白原(Fibrinogen,FIB)水平显著升高,凝血酶原时间(prothrombintime,PT)显著降低(P<0.01);多元Logistic回归分析逐步校正后,GMP140水平和冠心病密切相关(r=0.69,P<0.1)。结论血小板膜P2Y12受体活化介导的血小板高活状态引起的血浆高GMP140水平在冠心病的发生发展中起重要作用。Objective: To study the association of platelet membrane receptor P2Y12 mediated platelet activation and sigmal transmit pathway with coronary atherosclerotic heart disease. Methods: A total of 177 patients with coronay atherosclerotic heart disease ( CHD) and 61 controls with no history of coronary heart disease, thrombogenic and hemorrhagenic disrases in Sichuan region were studied by casecontrol study, Measured: with ADP induced platelet aggregation, plasma granule membrane protein (GMP140) and regulation cruor items. Results: Compared with controls, Maximum platelet aggregation ratio (MAR), plasma GMP140 and Fibrinogen (FIB) levels in CHD patients were significantly higher (P 〈 0.01 ), prothrombin time (FF) was significandy lower ( P 〈 0.01 ). Correlation analysis revealed that plasma GMPI40 was positively associated with coronay atherosclerotic heart disease (r =0. 69, P 〈 0.1). Conclusion: High level of plasma GMP140, which was induced by platelet surface receptor P2Y12 activation mediated high activation of platelet played important role of occurrence and progress of coronay atherosclerotic heart disease.
分 类 号:R541.4[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.148.247.50